Logo image of CLDI

CALIDI BIOTHERAPEUTICS INC (CLDI) Stock Analyst Ratings

NYSEARCA:CLDI - US3207033099 - Common Stock

1.56 USD
-0.18 (-10.34%)
Last: 8/25/2025, 8:11:45 PM
1.69 USD
+0.13 (+8.33%)
Pre-Market: 8/26/2025, 5:16:05 AM
Buy % Consensus

86

ChartMill assigns a Buy % Consensus number of 86% to CLDI. The Buy consensus is the weighted average rating of the current analysts ratings.

CLDI was analyzed by 7 analysts. The buy percentage consensus is at 86. So analysts seem to be very confident about CLDI.
In the previous month the buy percentage consensus was at a similar level.
CLDI was analyzed by 7 analysts. More opinions would make the average more meaningful.

Related screens

CLDI Historical Analyst RatingsCLDI Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -21 -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6

Related screens

CLDI Current Analyst RatingCLDI Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0.5 1 1.5 2 2.5
Up and Down Grades
Date Firm Action Rating
2024-06-27 Ladenburg Thalmann Initiate Buy
2024-05-15 Baird Maintains Outperform -> Outperform
2024-03-21 Baird Maintains Outperform -> Outperform
2024-03-21 HC Wainwright & Co. Maintains Buy -> Buy
2023-11-22 HC Wainwright & Co. Initiate Buy
2023-10-09 Baird Initiate Outperform